1. |
钱江.视网膜母细胞瘤治疗中应注意的若干问题[J]. 眼科,2009,18(6):367-369.
|
2. |
Shields CL, Lally SE, Leahey AM, et al. Targeted retinoblastoma management: when to use intravenous, intra-arterial, periocular, and intravitreal chemotherapy[J].Curr Opin Ophthalmol, 2014,25(5):374-385.
|
3. |
Kim JW, Ngai LK, Sadda S, et al. RetCam fluorescein angiography findings in eyes with advanced retinoblastoma[J]. Br J Ophthalmol, 2014,98(12):1666-1671.
|
4. |
Roth DB, Morales D, Feuer WJ, et al. Screening for retinopathy of prematurity employing the RetCam 120: sensitivity and specificity[J]. Arch Ophthalmol,2001,119(2):268-272.
|
5. |
赵培泉,张琦,许宇. 提高小儿视网膜疾病的认知水平,推动我国小儿视网膜疾病研究的深入开展[J]. 中华眼底病杂志,2014,30(1):1-5.
|
6. |
Shields CL,孙红,张军军, 等.视网膜母细胞瘤的临床表现和诊断[J].中华眼底病杂志,2004,20(2):118-121.
|
7. |
Shields CL, Mashayekhi A, Au AK, et al. The international classification of retinoblastoma predicts chemoreduction success[J]. Ophthalmology, 2006, 113(12):2276-2280.
|
8. |
Sury MR, Harker H,Begent J, et al. The management of infants and children for painless imaging[J]. Clin Radiol,2005,60(7):731-741.
|
9. |
Lerman J, Jöhr M. Inhalational anesthesia vs.total intravenous anesthesia(TIVA)for pediatric anesthesia[J]. Paediatr Anaesth, 2009,19(5):521-534.
|